Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001829126-26-002858·Indaptus Therapeutics, Inc.
Schedule 13D ownership disclosure
INDAPTUS THERAPEUTICS INC
Common Stock, $0.01 par value · CUSIP: 45339J105
Event date: 2026-03-23
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Yao YunReported CIK 0002120637
Shares: 41,991,000.00 · Class: 37.8%
- SINO LION VENTURES LtdReported CIK 0002120638
Shares: 38,895,000.00 · Class: 35.0%
- Xu Chenhao
Shares: 38,895,000.00 · Class: 35.0%
- Dai JunyiReported CIK 0002022463
Shares: 11,250,000.00 · Class: 10.1%
- Yang TingReported CIK 0002120636
Shares: 11,250,000.00 · Class: 10.1%
- Deng LinaReported CIK 0002120635
Shares: 5,550,000.00 · Class: 5.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001829126-26-002858
- Form type
- SCHEDULE 13D
- Filer
- Indaptus Therapeutics, Inc.
- CIK
- CIK 1857044
- Filed
- Mar 30, 2026
- Reporting period
- Mar 23, 2026
- Description
- Schedule 13D beneficial ownership